[Federal Register Volume 63, Number 38 (Thursday, February 26, 1998)] [Notices] [Pages 9794-9795] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 98-4964] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Vaccines and Related Biological Products Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). At least one portion of the meeting will be closed to the public. Name of Committee: Vaccines and Related Biological Products Advisory Committee. General Function of the Committee: To provide advice and recommendations to the agency on FDA regulatory issues. Date and Time: The meeting will be held on March 23, 1998, 7:45 a.m. to 6:20 p.m. Location: Ramada Inn, Embassy Ballroom, 8400 Wisconsin Ave., Bethesda, MD. Contact Person: Nancy T. Cherry or Denise H. Royster, Center for Biologics Evaluation and Research (HFM-21), Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443- 0572 in the Washington, DC area), code 12391. Please call the Information Line for up-to-date information on this meeting. Agenda: The committee will: (1) Discuss scientific and ethical considerations of a human challenge model using virulent Salmonella typhi bacteria; (2) complete recommendations pertaining to the influenza virus vaccine formulation for 1998 and 1999; and (3) hear short briefings on research programs in the Laboratories of DNA Viruses, Hepatitis Viruses, and Bacterial Polysaccharides. [[Page 9795]] Procedure: On March 23, 1998, from 7:45 a.m. to 4:50 p.m., the meeting is open to the public. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person by March 16, 1998. Oral presentations from the public will be scheduled between approximately 8 a.m. to 8:15 a.m. and between approximately 3:30 p.m. to 4:15 p.m. Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person before March 16, 1998, and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation. Closed Committee Deliberations: On March 23, 1998, from 4:50 p.m. to 6:20 p.m., the meeting will be closed to review data of a personal nature where disclosure would constitute a clearly unwarranted invasion of personal privacy (5 U.S.C. 552b(c)(6)). This portion of the meeting will be closed to permit discussion of this information. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: February 20, 1998. Michael A. Friedman, Deputy Commissioner of Operations. [FR Doc. 98-4964 Filed 2-25-98; 8:45 am] BILLING CODE 4160-01-F